These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12399222)

  • 1. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis.
    Sugimoto H; Kaneko T; Hirota M; Tezel E; Nakao A
    J Hepatol; 2002 Nov; 37(5):578-83. PubMed ID: 12399222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive analysis of portal pressure by contrast-enhanced sonography in patients with cirrhosis.
    Zhang CX; Hu J; Hu KW; Zhang C; Wang L; Xu JM
    J Ultrasound Med; 2011 Feb; 30(2):205-11. PubMed ID: 21266558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic transit times and liver elasticity compared with meld in predicting a 1 year adverse clinical outcome of a clinically diagnosed cirrhosis].
    Koller T; Piešťanská Z; Hlavatý T; Holomáň J; Glasa J; Payer J
    Vnitr Lek; 2016; 62(5):351-9. PubMed ID: 27319227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic transit time of ultrasound contrast in biopsy characterized liver disease.
    Pedersen JF; Larsen VA; Bytzer P; Madsen LG; Hamberg O
    Acta Radiol; 2005 Oct; 46(6):557-60. PubMed ID: 16334835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative diagnosis of early-stage liver cirrhosis with contrast-enhanced ultrasound--a clinical study.
    Shi Y; Wang XH; Xia GC; Lei CG
    Adv Clin Exp Med; 2012; 21(3):385-90. PubMed ID: 23214202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension.
    Luisa S; Vitale G; Sorbo AR; Maurizio P; Lodovico RG
    J Ultrasound; 2017 Mar; 20(1):43-52. PubMed ID: 28298943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obliteration of gastric varices improves the arrival time of ultrasound contrast agents in hepatic artery and vein.
    Furuichi Y; Moriyasu F; Sugimoto K; Taira J; Sano T; Miyata Y; Sofuni A; Itoi T; Nakamura I; Imai Y
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1526-31. PubMed ID: 23611144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
    Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
    Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound.
    Gauthier TP; Wasan HS; Muhammad A; Owen DR; Leen EL
    J Ultrasound Med; 2011 Mar; 30(3):379-85. PubMed ID: 21357560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography.
    Abbattista T; Ridolfi F; Consalvo GT; Brunelli E
    J Ultrasound Med; 2016 Oct; 35(10):2121-8. PubMed ID: 27503751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver hemodynamic flow balance by image-directed Doppler ultrasound evaluation in normal subjects.
    Bombelli L; Genitoni V; Biasi S; Materazzo C; Bonfanti G
    J Clin Ultrasound; 1991 Jun; 19(5):257-62. PubMed ID: 1651340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive diagnosis of compensated cirrhosis using an analysis of the time-intensity curve portal vein slope gradient on contrast-enhanced ultrasonography.
    Goto Y; Okuda K; Akasu G; Kinoshita H; Tanaka H
    Surg Today; 2014 Aug; 44(8):1496-505. PubMed ID: 24136649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical value of contrast-enhanced ultrasound in evaluating portal hypertension in patients with decompensated liver cirrhosis].
    Zhuang Y; Ding H; Han H; Mao F; Luo JJ; Chen SY; Wang WP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):270-4. PubMed ID: 27470625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
    Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
    Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent.
    Albrecht T; Blomley MJ; Cosgrove DO; Taylor-Robinson SD; Jayaram V; Eckersley R; Urbank A; Butler-Barnes J; Patel N
    Lancet; 1999 May; 353(9164):1579-83. PubMed ID: 10334257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal vein pulsatility in normal and cirrhotic adults without cardiac disease.
    Wachsberg RH; Needleman L; Wilson DJ
    J Clin Ultrasound; 1995 Jan; 23(1):3-15. PubMed ID: 7699090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis.
    Hirota M; Kaneko T; Sugimoto H; Kure S; Inoue S; Takeda S; Nakao A
    Liver Int; 2005 Apr; 25(2):337-42. PubMed ID: 15780059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins.
    Battista S; Bar F; Mengozzi G; Zanon E; Grosso M; Molino G
    J Hepatol; 1997 Jan; 26(1):75-80. PubMed ID: 9148026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of intrahepatic blood flow by Doppler ultrasonography: relationship between the hepatic vein, portal vein, hepatic artery and portal pressure measured intraoperatively in patients with portal hypertension.
    Zhang L; Yin J; Duan Y; Yang Y; Yuan L; Cao T
    BMC Gastroenterol; 2011 Jul; 11():84. PubMed ID: 21767412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.
    Lim AK; Taylor-Robinson SD; Patel N; Eckersley RJ; Goldin RD; Hamilton G; Foster GR; Thomas HC; Cosgrove DO; Blomley MJ
    Gut; 2005 Jan; 54(1):128-33. PubMed ID: 15591518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.